In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3β in neuronal apoptosis: Links to tau phosphorylation

European Journal of Neuroscience

Volumn 15, Issue 4, 2002, Pages 651-660

  Elyaman, W ^a,b   Terro, F ^b   Wong, N S ^a   Hugon, Jacques ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

Cell death; Kinase assay; Microtubules; Rat; Relocalization

Indexed keywords

ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; META TYROSINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SERINE; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICROTUBULE; MOLECULAR WEIGHT; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; RECEPTOR BLOCKING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL COMPARTMENTATION; CELL NUCLEUS; CYTOPLASM; CYTOSKELETON; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; MALE; NERVE DEGENERATION; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS; TAU PROTEINS;

EID: 18744385488     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.01899.x     Document Type: Article

References (50)

1. Andreadis, A., Wagner, B.K., Broderick, J.A. & Kosik, K.S. (1996) A tau promoter region without neuronal specificity. J. Neurochem., 66, 2257-2263.
2. Arendt, T., Holzer, M., Fruth, R., Bruckner, M.K. & Gartner, U. (1998) Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol. Aging, 19, 3-13.
3. Barth, A.I., Nathke, I.S. & Nelson, W.J. (1997) Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell. Biol., 9, 683-690.
4. Bhat, R.V., Shanley, J., Correll, M.P., Fieles, W.E., Keith, R.A., Scott, C.W. & Lee, C.M. (2000) Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. USA, 97, 11074-11079.
5. Bijur, G.N., De Sarno, P. & Jope, R.S. (2000) Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J. Biol. Chem., 275, 7583-7590.
6. Billingsley, M.L. & Kincaid, R.L. (1997) Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J., 323, 577-591.
7. Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Trojanowski, J.Q. & Lee, V.M. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron, 10, 1089-1099.
8. Buée-Sherrer, V., Buée, L., Hoff, P.R., Leveugle, B., Gilles, C., Loerzel, A.J., Perl, D.P. & Delacourte, A. (1995) Neurofibrillary degeneration in Amyotrophic Lateral Sclerosis Parcinsonism-Demantia complex of Guam: Immunohistochemical characterization of tau proteins. Am. J. Pathol., 68, 924-932.
9. Canu, N., Dus, L., Barbato, C., Ciotti, M.T., Brancolini, C., Rinaldi, A.M., Novak, M., Cattaneo, A., Bradbury, A. & Calissano, P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci., 18, 7061-7074.
10. Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N. & Cattaneo, A. (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. USA, 97, 6826-6831.
11. Couratier, P., Lesort, M., Sindou, P., Esclaire, F., Yardin, C. & Hugon, J. (1996) Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity. Mol. Chem. Neuropathol., 27, 259-273.
12. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. & Hemmings, B. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
13. Crowder, R.J. & Freeman, R.S. (2000) Glycogen synthase kinase-3beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J. Biol. Chem., 275, 34266-34271.
14. Czech, C., Tremp, G. & Pradier, L. (2000) Presenilins and Alzheimer's disease: Biological functions and pathogenic mechanisms. Prog. Neurobiol., 60, 363-384.
15. Davis, P.K. & Johnson, G.V. (1999a) Energy metabolism and protein phosphorylation during apoptosis: A phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells. Biochem. J., 340, 51-58.
16. Davis, P.K. & Johnson, G.V. (1999b) The microtubule binding of Tau and high molecular weight Tau in apoptotic PC12 cells is impaired because of altered phosphorylation. J. Biol. Chem., 274, 35686-35692.
17. Duyckaerts, C., Colle, M.A., Dessi, F., Grignon, Y., Piette, F. & Hauw, J.J. (1998) The progression of the lesions in Alzheimer disease: Insights from a prospective clinicopathological study. J. Neural. Transm. Suppl., 53, 119-126.
18. Goedert, M. (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci., 16, 460-465.
19. Goedert, M., Spillantini, M.G., Potier, M.C., Ulrich, J. & Crowther, R.A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain. EMBO J., 8, 393-399.
20. Gu, Y., Oyama, F. & Ihara, Y. (1996) Tau is widely expressed in rat tissues. J. Neurochem., 67, 1235-1244.
21. Hetman, M., Cavanaugh, J.E., Kimelman, D. & Xia, Z. (2000) Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci., 20, 2567-2574.
22. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O. & Woodgett, J.R. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature, 406, 86-90.
23. Hong, M., Chen, D.C., Klein, P.S. & Lee, V.M. (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem., 272, 25326-25332.
24. Hughes, K., Nikolakaki, E., Plyte, S.E., Totty, N.F. & Woodgett, J.R. (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J., 12, 803-808.
25. Hugon, J., Esclaire, F., Lesort, M., Kisby, G. & Spencer, P. (1998) Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab. Rev., 31, 635-647.
26. Hugon, J., Terro, F., Esclaire, F. & Yardin, C. (2000) Markers of apoptosis and models of programmed cell death in Alzheimer's disease. J. Neural. Transm. Suppl., 59, 125-131.
27. Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T.I., Stefovska, V., Turski, L. & Oleney, J.W. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science, 283, 70-74.
28. Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T. & Imahori, K. (1993) Glycogen synthase kinase-3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett., 325, 167-172.
29. Jenkins, S.M., Zinnerman, M., Garner, C. & Johnson, G.V. (2000) Modulation of tau phosphorylation and intracellular localization by cellular stress. Biochem. J., 345, 263-270.
30. Lesort, M., Blanchard, C., Yardin, C., Esclaire, F. & Hugon, J. (1997) Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Mol. Brain Res., 45, 127-132.
31. Levee, M.G., Dabrowska, M.I., Lelli, J.L. & Hinshaw, D.B. (1996) Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am. J. Physiol., 271, C1981-C1992.
32. Lovestone, S., Reynolds, C.H., Latimer, D., Davis, D.R., Anderton, B.H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J.R. & Miller, C.C.J. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol., 4, 1077-1086.
33. Lucas, J.J., Hernandez, F., Gomez-Ramos, P., Moran, M.A., Hen, R. & Avila, J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J., 20, 27-39.
34. Mandelkow, E.M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B. & Mandelkow, E. (1995) Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging, 16, 355-362.
35. Mills, J.C., Lee, V.K.Y. & Pittman, R. (1998) Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterise onset of the execution phase of apoptosis. J. Cell Sci., 111, 625-636.
36. Munoz-Montano, J.R., Moreno, F.J., Avila, J. & Diaz-Nido, J. (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett., 411, 183-188.
37. Murai, H., Okazaki, M. & Kikuchi, A. (1996) Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett., 392, 153-160.
38. Naruse, I. & Keino, H. (1995) Apoptosis in the developing CNS. Prog. Neurobiol., 47, 135-155.
39. Pap, M. & Cooper, G.M. (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem., 273, 19929-19932.
40. Rao, L., Perez, D. & White, E. (1996) Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol., 135, 1441-1455.
41. Seubert, P., Mawal-Dewan, M., Barbour, R., Jakes, R., Goedert, M., Johnson, G.V., Litersky, J.M., Schenk, D., Lieberburg, I., Trojanowski, J.Q. & Lee, U.M.Y. (1995) Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem., 270, 18917-18922.
42. Sindou, P., Lesort, M., Couratier, P., Yardin, C., Esclaire, F. & Hugon, J. (1994) Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex. Brain. Res., 646, 124-128.
43. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E. & Horton, W.E.J. (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol., 133, 225-230.
44. Spittaels, K., Van Den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., Van Lint, J., Vandenheede, J., Moechars, D., Loos, R. & Van Leuven, F. (2000) Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem., 275, 41340-41349.
45. Stambolic, V. & Woodgett, J.R. (1994) Mitogen inactivation of glycogen synthase kinase-3β by insulin in intact cells via serine-9 phosphorylation. Biochem. J., 303, 701-704.
46. Su, J.H., Anderson, A.J., Cummings, B.J. & Cotman, C.W. (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport, 5, 2529-2533.
47. Torreilles, F., Roquet, F., Granier, C., Pau, B. & Mourton-Gilles, C. (2000) Binding specificity of monoclonal antibody AD2: Influence of the phosphorylation state of tau. Brain Res. Mol. Brain Res., 78, 181-185.
48. Tsujio, I., Tanaka, T., Kudo, T., Nishikawa, T., Shinozaki, K., Grundke-Iqbal, I., Iqbal, K. & Takeda, M. (2000) Inactivation of glycogen synthase kinase-3 by protein kinase C delta: Implications for regulation of tau phosphorylation. FEBS Lett., 469, 111-117.
49. Yardin, C., Terro, F., Esclaire, F., Rigaud, M. & Hugon, J. (1998) Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein. Neurosci. Lett., 250, 1-4.
50. Zhang, J. & Johnson, G.V. (2000) Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells. J. Neurochem., 75, 2346-2357.